We advise to exercise Theralase Technologies fundamental analysis to find out if markets are presently mispricing the firm. In other words this technique allows you to confirm available indicators of Theralase Technologies as well as the relationship between them. We were able to interpolate thirty available drivers for Theralase Technologies, which can be compared to its competition. The stock experiences an unexpected downward movement. The market is reacting to new fundamentals. Check odds of Theralase Technologies to be traded at C$0.2496 in 90 days. Key indicators impacting Theralase Technologies' financial strength include:
Please note, the imprecision that can be found in Theralase Technologies' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Theralase Technologies. Check Theralase Technologies' Beneish M Score to see the likelihood of Theralase Technologies' management manipulating its earnings.
Theralase Technologies Stock Summary
Theralase Technologies competes with Theralase Technologies, Reliq Health, and Microbix Biosystems. Theralase Technologies Inc., a clinical stage pharmaceutical company, engages in the research and development of photo dynamic compounds and their associated drug formulations to destroy various cancers in Canada, the United States, and internationally. Theralase Technologies Inc. was founded in 1995 and is headquartered in Toronto, Canada. THERALASE TECHNOLOGIES operates under Medical Devices classification in Canada and is traded on TSX Venture Exchange.
You should never invest in Theralase Technologies without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Theralase Stock, because this is throwing your money away. Analyzing the key information contained in Theralase Technologies' financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Theralase Technologies Key Financial Ratios
There are many critical financial ratios that Theralase Technologies' investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Theralase Technologies reports annually and quarterly.
Comparative valuation techniques use various fundamental indicators to help in determining Theralase Technologies's current stock value. Our valuation model uses many indicators to compare Theralase Technologies value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Theralase Technologies competition to find correlations between indicators driving Theralase Technologies's intrinsic value. More Info.
Theralase Technologies is rated fourth in return on equity category among its peers. It also is rated fourth in return on asset category among its peers . At this time, Theralase Technologies' Return On Equity is fairly stable compared to the past year. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Theralase Technologies' earnings, one of the primary drivers of an investment's value.
Theralase Technologies Systematic Risk
Theralase Technologies' systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Theralase Technologies volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was fourteen with a total number of output elements of fourty-seven. The Beta measures systematic risk based on how returns on Theralase Technologies correlated with the market. If Beta is less than 0 Theralase Technologies generally moves in the opposite direction as compared to the market. If Theralase Technologies Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Theralase Technologies is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Theralase Technologies is generally in the same direction as the market. If Beta > 1 Theralase Technologies moves generally in the same direction as, but more than the movement of the benchmark.
Theralase Technologies Total Assets Over Time
Theralase Technologies Thematic Clasifications
Theralase Technologies is part of IT investing theme. If you are a theme-oriented, socially responsible, and at the same time, a result-driven investor, you can align your investing habits with your values without jeopardizing your expectations about returns. You can easily create an optimal portfolio of stocks, ETFs, funds, or cryptocurrencies based on a specific theme of your liking. Information technology and IT services. Information Technology (IT) companies and IT service providers across different domains
This theme covers Information technology and IT services. Information Technology (IT) companies and IT service providers across different domains. Get More Thematic Ideas
Today, most investors in Theralase Technologies Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Theralase Technologies' growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Theralase Technologies growth as a starting point in their analysis.
Theralase Technologies December 13, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Theralase Technologies help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Theralase Technologies. We use our internally-developed statistical techniques to arrive at the intrinsic value of Theralase Technologies based on widely used predictive technical indicators. In general, we focus on analyzing Theralase Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Theralase Technologies's daily price indicators and compare them against related drivers.
When running Theralase Technologies' price analysis, check to measure Theralase Technologies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Theralase Technologies is operating at the current time. Most of Theralase Technologies' value examination focuses on studying past and present price action to predict the probability of Theralase Technologies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Theralase Technologies' price. Additionally, you may evaluate how the addition of Theralase Technologies to your portfolios can decrease your overall portfolio volatility.